Nuveen Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$13.4M Buy
149,116
+39
+0% +$3.51K ﹤0.01% 1433
2024
Q3
$14.7M Buy
149,077
+1,182
+0.8% +$117K ﹤0.01% 1380
2024
Q2
$13.7M Sell
147,895
-58,005
-28% -$5.38M ﹤0.01% 1375
2024
Q1
$19.5M Sell
205,900
-269
-0.1% -$25.5K 0.01% 1198
2023
Q4
$18.4M Buy
206,169
+18,630
+10% +$1.66M 0.01% 1214
2023
Q3
$13.7M Buy
187,539
+62
+0% +$4.53K ﹤0.01% 1286
2023
Q2
$15.6M Sell
187,477
-132
-0.1% -$11K 0.01% 1240
2023
Q1
$14.3M Buy
187,609
+34,817
+23% +$2.65M 0.01% 1256
2022
Q4
$12.7M Buy
152,792
+99,163
+185% +$8.23M ﹤0.01% 1338
2022
Q3
$4.25M Buy
+53,629
New +$4.25M ﹤0.01% 1995
2020
Q4
Sell
-39,006
Closed -$4.35M 3302
2020
Q3
$4.35M Sell
39,006
-8,903
-19% -$992K ﹤0.01% 1987
2020
Q2
$5.36M Sell
47,909
-20,487
-30% -$2.29M ﹤0.01% 1856
2020
Q1
$5.3M Buy
68,396
+39,253
+135% +$3.04M ﹤0.01% 1687
2019
Q4
$2.77M Sell
29,143
-15,884
-35% -$1.51M ﹤0.01% 2287
2019
Q3
$3.43M Sell
45,027
-29,284
-39% -$2.23M ﹤0.01% 2147
2019
Q2
$6.52M Buy
74,311
+25,697
+53% +$2.25M ﹤0.01% 1845
2019
Q1
$4.4M Buy
48,614
+21,470
+79% +$1.94M 0.02% 528
2018
Q4
$1.95M Sell
27,144
-123,215
-82% -$8.84M 0.01% 622
2018
Q3
$14.4M Buy
150,359
+2,674
+2% +$256K 0.08% 372
2018
Q2
$14.1M Sell
147,685
-599
-0.4% -$57K 0.09% 328
2018
Q1
$13M Buy
148,284
+18,069
+14% +$1.59M 0.08% 331
2017
Q4
$11.1M Sell
130,215
-5,343
-4% -$453K 0.07% 370
2017
Q3
$11.7M Buy
135,558
+13,961
+11% +$1.21M 0.08% 361
2017
Q2
$9.39M Buy
+121,597
New +$9.39M 0.06% 422